Cargando…
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody
SARS-CoV-2 infection causes a range of clinical presentations and induces changes in both innate and adaptive branches of the immune system. Furthermore, direct viral action to the cells of the lung promotes over-expression of the epidermal growth factor receptor (EGFR) which triggers pro-inflammato...
Autores principales: | Saavedra, Danay, Añé-Kourí, Ana L., Gregorich, Egda M. Llanez, Mena, Jilma, Lorenzo-Luaces, Patricia, Londres, Henrry Diaz, Martínez, Aray Hernández, Armada, Jorge Jiménez, Sánchez, Yamilka Hernández, González, Yaneth Zamora, Troche, Mayelin, Medel, Loipa, Ramos, Mayra, Crombet, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Immunological Societies. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512531/ https://www.ncbi.nlm.nih.gov/pubmed/36174772 http://dx.doi.org/10.1016/j.imlet.2022.09.005 |
Ejemplares similares
-
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment
por: Londres, Henrry Diaz, et al.
Publicado: (2022) -
Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario
por: Diaz, Henrry, et al.
Publicado: (2022) -
Nimotuzumab for COVID-19: case series
por: Abdo Cuza, Anselmo A, et al.
Publicado: (2021) -
CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients
por: Saavedra, Danay, et al.
Publicado: (2017) -
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Suárez, Gisela María, et al.
Publicado: (2022)